These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 26805075)

  • 21. [A Case of Wilson's Disease with Psoriasis Vulgaris, Complicated with Hepatocellular Carcinoma and Successfully Treated with Sorafenib].
    Nakagawa T; Chubachi S
    Gan To Kagaku Ryoho; 2015 Sep; 42(9):1107-9. PubMed ID: 26469170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can sorafenib increase survival for recurrent hepatocellular carcinoma after liver transplantation? A pilot study.
    Alsina AE; Makris A; Nenos V; Sucre E; Arrobas J; Franco E; Kemmer N
    Am Surg; 2014 Jul; 80(7):680-4. PubMed ID: 24987900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sorafenib treatment for recurrent hepatocellular carcinoma after liver transplantation.
    Sotiropoulos GC; Nowak KW; Fouzas I; Vernadakis S; Kykalos S; Klein CG; Paul A
    Transplant Proc; 2012 Nov; 44(9):2754-6. PubMed ID: 23146514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative treatments in advanced hepatocellular carcinoma patients with progressive disease after sorafenib treatment: a prospective multicenter cohort study.
    Nakano M; Tanaka M; Kuromatsu R; Nagamatsu H; Satani M; Niizeki T; Okamura S; Iwamoto H; Shimose S; Shirono T; Noda Y; Koga H; Torimura T;
    Oncotarget; 2016 Sep; 7(39):64400-64409. PubMed ID: 27462865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Three cases of recurrent hepatocellular carcinoma treated with laparoscopic hepatectomy after oral administration of sorafenib].
    Komatsu H; Tsukamoto T; Kodai S; Kanazawa A; Shimizu S; Yamazoe S; Ohira G; Nakajima T; Nakai T; Kawasaki Y; Kioka K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1672-4. PubMed ID: 24393884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sorafenib as an adjuvant therapy for resectable hepatocellular carcinoma: A single center experience.
    Antoniou EA; Margonis GA; Amini N; Anastasiou M; Angelou A; Kim Y; Kouraklis G
    J BUON; 2016; 21(5):1189-1194. PubMed ID: 27837622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sorafenib in the treatment of recurrent hepatocellular carcinoma after liver transplantation: a report of four cases.
    Hong YM; Yoon KT; Cho M; Kang DH; Kim HW; Choi CW; Park SB; Heo J; Woo HY; Lim W
    Korean J Gastroenterol; 2015 Apr; 65(4):246-51. PubMed ID: 25896160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of Sorafenib Outcome: Focusing on the Clinical Course in Patients with Hepatocellular Carcinoma.
    Ogasawara S; Chiba T; Ooka Y; Suzuki E; Inoue M; Wakamatsu T; Tawada A; Yokosuka O
    PLoS One; 2016; 11(8):e0161303. PubMed ID: 27537374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Case analysis of complete remission of advanced hepatocellular carcinoma achieved with sorafenib.
    Liu D; Liu A; Peng J; Hu Y; Feng X
    Eur J Med Res; 2015 Feb; 20(1):12. PubMed ID: 25649133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes of patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective study of routine clinical practice in multi-institutions.
    Lee SH; Song IH; Noh R; Kang HY; Kim SB; Ko SY; Lee ES; Kim SH; Lee BS; Kim AN; Chae HB; Kim HS; Lee TH; Kang YW; Lee JD; Lee HY
    BMC Cancer; 2015 Apr; 15():236. PubMed ID: 25885683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The possible role of sorafenib as a part of the multimodal treatment for hepatocellular carcinoma].
    Ishiko T; Beppu T; Chikamoto A; Tanaka H; Masuda T; Okabe H; Mima K; Horino K; Takamori H; Nakahara O; Baba H
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2499-501. PubMed ID: 22202426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical parameters predictive of outcomes in sorafenib-treated patients with advanced hepatocellular carcinoma.
    Cho JY; Paik YH; Lim HY; Kim YG; Lim HK; Min YW; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Liver Int; 2013 Jul; 33(6):950-7. PubMed ID: 23601249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Efficacy of Continued Sorafenib Treatment after Radiologic Confirmation of Progressive Disease in Patients with Advanced Hepatocellular Carcinoma.
    Wada Y; Takami Y; Tateishi M; Ryu T; Mikagi K; Saitsu H
    PLoS One; 2016; 11(1):e0146456. PubMed ID: 26745625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of locoregional therapies in patients with advanced hepatocellular carcinoma treated with sorafenib.
    Sarpel U; Spivack JH; Berger Y; Heskel M; Aycart SN; Sweeney R; Edwards MP; Labow DM; Kim E
    HPB (Oxford); 2016 May; 18(5):411-8. PubMed ID: 27154804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation.
    de'Angelis N; Landi F; Nencioni M; Palen A; Lahat E; Salloum C; Compagnon P; Lim C; Costentin C; Calderaro J; Luciani A; Feray C; Azoulay D
    Prog Transplant; 2016 Dec; 26(4):348-355. PubMed ID: 27555074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sorafenib combined with percutaneous radiofrequency ablation for the treatment of medium-sized hepatocellular carcinoma.
    Kan X; Jing Y; Wan QY; Pan JC; Han M; Yang Y; Zhu M; Wang Q; Liu KH
    Eur Rev Med Pharmacol Sci; 2015; 19(2):247-55. PubMed ID: 25683938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sorafenib: the gold standard therapy in advanced hepatocellular carcinoma and beyond.
    Gadaleta-Caldarola G; Divella R; Mazzocca A; Infusino S; Ferraro E; Filippelli G; Daniele A; Sabbà C; Abbate I; Brandi M
    Future Oncol; 2015; 11(16):2263-6. PubMed ID: 26260805
    [No Abstract]   [Full Text] [Related]  

  • 38. Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review.
    de'Angelis N; Landi F; Carra MC; Azoulay D
    World J Gastroenterol; 2015 Oct; 21(39):11185-98. PubMed ID: 26494973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative efficacy of sorafenib versus best supportive care in recurrent hepatocellular carcinoma after liver transplantation: a case-control study.
    Sposito C; Mariani L; Germini A; Flores Reyes M; Bongini M; Grossi G; Bhoori S; Mazzaferro V
    J Hepatol; 2013 Jul; 59(1):59-66. PubMed ID: 23500153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-progression survival in patients with advanced hepatocellular carcinoma resistant to sorafenib.
    Ogasawara S; Chiba T; Ooka Y; Suzuki E; Kanogawa N; Saito T; Motoyama T; Tawada A; Kanai F; Yokosuka O
    Invest New Drugs; 2016 Apr; 34(2):255-60. PubMed ID: 26769245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.